9 Results for "

HVA

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "HVA" in MCE Product Catalog:

Cat. No.: HY-130118
CAS No.: 2377379-39-8
Purity:  99.95%
MRGPRX1 agonist 1 is a highly potent MRGPRX1 agonist (EC50=50 nM) with greater than 50-fold selectivity for δ, μ, and κ opioid receptors. MRGPRX1 agonist 1 is inactive against MRGPRC11. MRGPRC11 inhibits high voltage-activated (HVA) Ca 2+ currents, reduces neurotransmitter release, and mitigates nociceptive transmission in the spinal cord. MRGPRX1 agonist 1 is useful for the study of chronic pain, especially neuropathic pain .
loading...
    loading...
Cat. No.: HY-16677A
CAS No.: 120635-25-8
Synonyms: MDL72974A
Target:  

Monoamine Oxidase VAP-1

Research Areas:  

Neurological Disease

Mofegiline hydrochloride (MDL-72974A) is an orally active and blood-brain barrier-penetrant MAO-B/SSAO selective inhibitor, with an IC50 of 3.6 nM for MAO-B and 10 nM for SSAO. Mofegiline hydrochloride is a cationic amphiphilic compound that can induce indirect sympathomimetic effects, lysosomal accumulation, hERG channel interactions, phospholipidosis, and cell death. Mofegiline hydrochloride protects mice from MPTP-induced depletion of striatal dopamine, DOPAC, and HVA. Mofegiline hydrochloride can be used in research related to Parkinson's disease .
loading...
    loading...
Cat. No.: HY-125339
CAS No.: 125628-97-9
Purity:  98.0%
Target:  

COMT Apoptosis

Research Areas:  

Neurological Disease Cancer

Ro 41-0960 is a CNS-penetrant, orally active catechol-O-methyl transferase (COMT) inhibitor. Ro 41-0960 reduces dopamine catabolism, increases striatal dopamine and DOPAC levels, decreases striatal HVA levels, induces apoptosis, inhibits proliferation and extracellular matrix formation in uterine fibroid cells. Ro 41-0960 arrests or shrinks uterine fibroid lesions in rats. Ro 41-0960 can be used for the research of Parkinson’s disease, uterine leiomyomas, and breast cancer .
loading...
    loading...
Cat. No.: HY-W002110
CAS No.: 1131-94-8
Synonyms: 3-Hydroxy-4-methoxyphenylacetic acid; iso-HVA; Homoisovanillic acid
Isohomovanillic acid (3-Hydroxy-4-methoxyphenylacetic acid) is a product of catecholamine metabolism. Isohomovanillic acid can be isolated from urine. Isohomovanillic acid can be used in the research of Parkinson's disease .
loading...
    loading...
Cat. No.: HY-116195
CAS No.: 126-91-0
Purity:  ≥98.0%
Synonyms: (-)-Linalool
L-Linalool ((-)-Linalool) is a naturally derived monoterpene alcohol with oral activity, possessing neuroprotective, anti-inflammatory, and antioxidant activities. L-Linalool is a 5-HT3 receptor inhibitor and a benzodiazepine-responsive GABAA receptor enhancer. L-Linalool reduces nitrite and lipid peroxidation in the brain and partially prevents the decrease of striatal dopamine, DOPAC, and HVA. L-Linalool exhibits neuroprotective effects in hemiparkinsonian rats, cortical oxygen-glucose deprivation injury, and Alzheimer's disease models. L-Linalool prevents the decrease in tyrosine hydroxylase and dopamine transporter expression. L-Linalool can be used in research related to diseases such as Parkinson's disease and Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-W002110R
CAS No.: 1131-94-8
Synonyms: 3-Hydroxy-4-methoxyphenylacetic acid (Standard); iso-HVA (Standard); Homoisovanillic acid (Standard)
Isohomovanillic acid (Standard) is an analytical standard of Isohomovanillic acid (HY-W002110). This product is intended for research and analytical applications. Isohomovanillic acid (3-Hydroxy-4-methoxyphenylacetic acid) is a product of catecholamine metabolism. Isohomovanillic acid can be isolated from urine. Isohomovanillic acid can be used in the research of Parkinson's disease .
loading...
    loading...
Cat. No.: HY-19061
CAS No.: 111757-17-6
Target:  

COMT

Research Areas:  

Neurological Disease

CGP 28014 is a catechol-O-methyltransferase inhibitor. CGP 28014 can lower HVA levels and increase DOPAC levels in the striatum of rats, making it useful for research on Parkinson's disease .
loading...
    loading...
Cat. No.: HY-116195R
CAS No.: 126-91-0
Purity:  98.10%
Synonyms: (-)-Linalool (Standard)
L-Linalool (Standard) ((-)-Linalool (Standard)) is the analytical standard of L-Linalool (HY-116195). This product is intended for research and analytical applications. L-Linalool ((-)-Linalool) is a naturally derived monoterpene alcohol with oral activity, possessing neuroprotective, anti-inflammatory, and antioxidant activities. L-Linalool is a 5-HT3 receptor inhibitor and a benzodiazepine-responsive GABAA receptor enhancer. L-Linalool reduces nitrite and lipid peroxidation in the brain and partially prevents the decrease of striatal dopamine, DOPAC, and HVA. L-Linalool exhibits neuroprotective effects in hemiparkinsonian rats, cortical oxygen-glucose deprivation injury, and Alzheimer's disease models. L-Linalool prevents the decrease in tyrosine hydroxylase and dopamine transporter expression. L-Linalool can be used in research related to diseases such as Parkinson's disease and Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-16677
CAS No.: 119386-96-8
Synonyms: MDL-72974
Target:  

Monoamine Oxidase VAP-1

Research Areas:  

Neurological Disease

Mofegiline (MDL-72974) is an orally active and blood-brain barrier-penetrant MAO-B/SSAO selective inhibitor, with an IC50 of 3.6 nM for MAO-B and 10 nM for SSAO. Mofegiline is a cationic amphiphilic compound that can induce indirect sympathomimetic effects, lysosomal accumulation, hERG channel interactions, phospholipidosis, and cell death. Mofegiline protects mice from MPTP-induced depletion of striatal dopamine, DOPAC, and HVA. Mofegiline can be used in research related to Parkinson's disease .
loading...
    loading...